PRESS RELEASE Dr Nicco's new Chief Operating Officer (COO) position will give her a broader mandate at BioSenic, where she is currently responsible for R&D programs. Mont-Saint-Guibert, Belgium, January 10, 2024, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, and its subsidiary Medsenic SAS, today announces the promotion of Dr Carole Nicco to Chief Operating Officer (COO) in ad
Minister and civil-rights activist Bishop William Barber II was removed from a North Carolina movie theater after a dispute over accessible seating, according to police and news outlets.
Minister and civil-rights activist Bishop William Barber II was removed from a North Carolina movie theater after a dispute over accessible seating, according to police and news outlets.
Matthias Bodenstedt, the CFO of MoonLake Immunotherapeutics (NASDAQ:MLTX), executed a sale of 100,000 shares in the company on December 20, 2023, according to a recent SEC Filing.